Effects of the route of oestrogen administration on IGF-1 and IGFBP-3 in healthy postmenopausal women: results from a randomized placebo-controlled study.
about
Insulin-like growth factor-I and cancer mortality in older men.Age related secretary pattern of growth hormone, insulin-like growth factor-I & insulin-like growth factor binding protein-3 in postmenopausal women.WAP four-disulfide core domain protein 2 gene(WFDC2) is a target of estrogen in ovarian cancer cellsSexual dimorphism in skeletal muscle protein turnoverApplication of serum proteomics to the Women's Health Initiative conjugated equine estrogens trial reveals a multitude of effects relevant to clinical findingsGrowth hormone, menopause and ageing: no definite evidence for 'rejuvenation' with growth hormone.Testosterone and progesterone, but not estradiol, stimulate muscle protein synthesis in postmenopausal women.Effects of the SERM raloxifene on calcium and phosphate metabolism in healthy middle-aged men.Turner syndrome--issues to consider for transition to adulthood.Effect of NFE2L2 genetic polymorphism on the association between oral estrogen therapy and the risk of venous thromboembolism in postmenopausal women.Coronary heart disease and HRT in France: MISSION study prospective phase results.Decreased IGF-1 concentration during the first trimester of pregnancy in women with normal somatotroph function.Cognitive function in association with sex hormones in postmenopausal women.Tamoxifen enhances the control of acromegaly treated with somatostatin analog lanreotide.
P2860
Q33738660-6CC1214A-EBD1-4230-B5CF-02C3B6F0249BQ33833662-3EFE4117-CE9F-44DB-A86F-288D2E32F53DQ36629304-8D7CAD2D-3274-42D0-B34F-375915468566Q36698656-D8B1ED4B-A120-4C6E-B9C6-251D2C36AF1FQ37198459-184EDB42-D541-4A14-843E-C664AFB25CF1Q37396676-05923975-C212-40C1-8DD1-5CFB3DD350E9Q37428970-8047B5F2-6DF4-4647-91A4-1947E8618AFCQ37430447-5D7AF9C6-EE54-4A36-9FB1-1E05FCC779D8Q38297541-F404E2CD-D7C4-45E6-BF80-F59124C9A8A9Q43494908-5019BEF0-5E91-4BF5-A3C5-EF39D62CB3B2Q44251617-37619036-648F-4CA7-B094-038701493FD8Q48569734-1EE3A720-0282-4813-B3E6-EC654E0BD98BQ50785697-849BEADE-5AE2-46D2-AB1B-D813DA651BB0Q51518444-5AAF4136-6B35-4044-8433-D6AC351D798C
P2860
Effects of the route of oestrogen administration on IGF-1 and IGFBP-3 in healthy postmenopausal women: results from a randomized placebo-controlled study.
description
2007 nî lūn-bûn
@nan
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Effects of the route of oestro ...... ized placebo-controlled study.
@ast
Effects of the route of oestro ...... ized placebo-controlled study.
@en
Effects of the route of oestro ...... ized placebo-controlled study.
@nl
type
label
Effects of the route of oestro ...... ized placebo-controlled study.
@ast
Effects of the route of oestro ...... ized placebo-controlled study.
@en
Effects of the route of oestro ...... ized placebo-controlled study.
@nl
prefLabel
Effects of the route of oestro ...... ized placebo-controlled study.
@ast
Effects of the route of oestro ...... ized placebo-controlled study.
@en
Effects of the route of oestro ...... ized placebo-controlled study.
@nl
P2093
P2860
P1476
Effects of the route of oestro ...... ized placebo-controlled study.
@en
P2093
Dominique Mottier
Emmanuel Oger
Emmanuel Sonnet
Karine Lacut
Nathalie Roudaut
Véronique Kerlan
P2860
P304
P356
10.1111/J.1365-2265.2007.02783.X
P577
2007-05-01T00:00:00Z